The recent inclusion of the FUBP1 gene in the “long-tail driver” category of the less-frequently mutated genes due to its alternative splicing regulatory role in several oncogenes and tumor suppressors [288], makes it a very attractive therapeutic target. Here, FUBP1 is linked to neoplasm.